Macaya Douoguih

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans”.

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

Nature(2021)10.1038/s41586-021-03681-2

N/A

10.5DataRank · unranked

353 citations

Jingyou Yu, Jinyan Liu, Abishek Chandrashekar, Erica N. Borducchi, Lisa H. Tostanoski +26 more

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

New England Journal of Medicine(2022)10.1056/nejmoa2117608

N/A

4.6DataRank · unranked

251 citations

Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Beatriz Grinsztejn +24 more

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01262-1

N/A

2.6DataRank · unranked

93 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00506-0

N/A

2.0DataRank · unranked

89 citations

An Vandebosch, Jerald Sadoff, Mathieu Le Gars, Carla Truyers, D. Lowson +95 more

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(21)00125-0

N/A

1.7DataRank · unranked

95 citations

Daniela Manno, Muhammed O. Afolabi, Babajide Keshinro, Viki Bockstal, Baimba Rogers +87 more

First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study

PLoS ONE(2022)10.1371/journal.pone.0274906

N/A

1.3DataRank · unranked

32 citations

Georgi Shukarev, Chelsea McLean, Neil Goldstein, Stephan Bart, Auguste Gaddah +13 more

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial

Nature Communications(2024)10.1038/s41467-024-53727-y

N/A

0.644DataRank · unranked

21 citations

Ollivier Hyrien, Youyi Fong, David Benkeser, Sanne Roels, Daniel J Stieh +56 more

Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study

Vaccines(2024)10.3390/vaccines12020210

N/A

0.348DataRank · unranked

7 citations

Andrew J. Pollard, Catherine Schmidt‐Mutter, Fabrice Lainé, George PrayGod, Hannah Kibuuka +13 more

Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trial

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103016

N/A

0.249DataRank · unranked

4 citations

Gloria Aguilar, Nathalie Vaissière, Carla Truyers, Pedro Ylisastigui, Erik Buntinx +15 more

Ad26.COV2.S COVID-19 Vaccine Safety And Immunogenicity in Adolescents 16–17 Years of Age

Journal of the Pediatric Infectious Diseases Society(2024)10.1093/jpids/piae098

N/A

0DataRank · unranked

0 citations

Mathieu Le Gars, Vicky Cárdenas, Nathalie Vaissière, Jerald Sadoff, Carla Truyers +7 more

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate

npj Vaccines(2020)10.1038/s41541-020-00261-9

N/A

0DataRank · unranked

75 citations

Jenny Hendriks, Thierry Van Effelterre, Bart Spiessens, Liesbeth Dekking, Laura Solforosi +24 more

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

iScience(2025)10.1016/j.isci.2025.113660

N/A

0DataRank · unranked

1 citations

Youyi Fong, Lars van der Laan, Fei Heng, Ying Huang, Yiwen Lu +61 more

Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa586

N/A

0DataRank · unranked

40 citations

Viki Bockstal, Stephan Bart, Kerstin Lühn, Cynthia Robinson, Auguste Gaddah +3 more

Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting

medRxiv(2021)10.1101/2021.08.25.21262569

N/A

0DataRank · unranked

23 citations

Mathieu Le Gars, Vicky Cárdenas, Georgi Shukarev, Nathalie Vaissière, Dirk Heerwegh +10 more

Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19

medRxiv(2021)10.1101/2021.07.05.21259918

N/A

0DataRank · unranked

21 citations

Kathryn E. Stephenson, Jerald Sadoff, Jingyou Yu, Aiquan Chang, Makda S. Gebre +12 more

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

UNC Libraries(2021)10.17615/phnx-3j92

N/A

0DataRank · unranked

0 citations

Kathryn E. Stephenson, Jingyou Yu, Aiquan Chang, Johan Van Hoof, Sally Shin +26 more

Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector–based COVID‐19 vaccine

Immunological Reviews(2022)10.1111/imr.13088

N/A

0DataRank · unranked

27 citations

Jenny Hendriks, Jerald Sadoff, Martin Ryser, Frank Struyf, Macaya Douoguih +2 more

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

npj Vaccines(2022)10.1038/s41541-022-00564-z

N/A

0DataRank · unranked

21 citations

Maarten Leyssen, Dirk Heerwegh, Bart Spiessens, Cynthia Robinson, Jeroen N. Stoop +13 more

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.04.06.22272763

N/A

0DataRank · unranked

12 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory

EBioMedicine(2023)10.1016/j.ebiom.2023.104562

N/A

0DataRank · unranked

10 citations

Houreratou Barry, Mark Kieh, Zacchaeus Anywaine, Baimba Rogers, Seydou Doumbia +22 more